CONFERENCE
COMMITTEE REP. NO. 27
Honolulu, Hawaii
, 2023
RE: S.B. No. 602
S.D. 2
H.D. 1
C.D. 1
Honorable Ronald D. Kouchi
President of the Senate
Thirty-Second State Legislature
Regular Session of 2023
State of Hawaii
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirty-Second State Legislature
Regular Session of 2023
State of Hawaii
Sirs:
Your Committee on Conference on the disagreeing vote of the Senate to the amendments proposed by the House of Representatives in S.B. No. 602, S.D. 2, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO HEALTH,"
having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.
The purpose of this measure is to:
(1) Authorize pharmacists to order, perform, and report the results of certain Clinical Laboratory Improvement Amendments of 1988 (CLIA)-waived tests; and
(2) Specify educational and permitting requirements for the ordering, performance, and reporting the results of certain CLIA-waived tests.
Your
Committee on Conference has
amended this measure by:
(1) Clarifying that, for any CLIA-waived tests performed, pharmacists shall follow all applicable state laws and rules regarding the reporting of all diseases, rather than just communicable diseases; and
(2) Making it effective upon its approval.
As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of S.B. No. 602, S.D. 2, H.D. 1, as amended herein, and recommends that it pass Final Reading in the form attached hereto as S.B. No. 602, S.D. 2, H.D. 1, C.D. 1.
Respectfully submitted on behalf of the managers:
ON THE PART OF THE HOUSE |
|
ON THE PART OF THE SENATE |
____________________________ MARK M. NAKASHIMA Chair |
|
____________________________ JOY A. SAN BUENAVENTURA Chair |
|
|
____________________________ JARRETT KEOHOKALOLE Co-Chair |
|
|
|
|
|
|